2022
DOI: 10.3389/fendo.2022.836527
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Environmental Endocrine Disruptors Associated With the Age at Menarche by Integrating a Transcriptome-Wide Association Study With Chemical-Gene-Interaction Analysis

Abstract: Menarche is the first occurrence of menstrual bleeding and one of the most important events of female puberty. Alarmingly, over the last several decades, the mean age at menarche (AAM) has decreased. Environmental endocrine disruptors (EEDs) are chemicals that may interfere with the endocrine system, resulting in adverse developmental, immunological, neurological, and reproductive effects in humans. Thus, the effects of EEDs on fertility and reproduction are growing concerns in modern societies. In this study,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 80 publications
(77 reference statements)
0
0
0
Order By: Relevance
“…These data can be leveraged in concert with GWAS to conduct transcriptome-wide association studies (TWAS) in which associations between genetically predicted gene expression levels and outcomes can be statistically inferred (87)(88)(89)(90). TWAS have been conducted for uterine fibroids (91,92), breast cancer (93)(94)(95), age at menopause (96), mammographic density (93), postpartum depression (97), age at menarche (98), ovarian cancer (99,100), and other outcomes.…”
Section: Omics In Women's Healthmentioning
confidence: 99%
“…These data can be leveraged in concert with GWAS to conduct transcriptome-wide association studies (TWAS) in which associations between genetically predicted gene expression levels and outcomes can be statistically inferred (87)(88)(89)(90). TWAS have been conducted for uterine fibroids (91,92), breast cancer (93)(94)(95), age at menopause (96), mammographic density (93), postpartum depression (97), age at menarche (98), ovarian cancer (99,100), and other outcomes.…”
Section: Omics In Women's Healthmentioning
confidence: 99%